1. Home
  2. BCYC vs PAR Comparison

BCYC vs PAR Comparison

Compare BCYC & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • PAR
  • Stock Information
  • Founded
  • BCYC 2009
  • PAR 1968
  • Country
  • BCYC United Kingdom
  • PAR United States
  • Employees
  • BCYC N/A
  • PAR N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • PAR Office Equipment/Supplies/Services
  • Sector
  • BCYC Health Care
  • PAR Miscellaneous
  • Exchange
  • BCYC Nasdaq
  • PAR Nasdaq
  • Market Cap
  • BCYC 1.7B
  • PAR 2.0B
  • IPO Year
  • BCYC 2019
  • PAR N/A
  • Fundamental
  • Price
  • BCYC $20.54
  • PAR $52.75
  • Analyst Decision
  • BCYC Buy
  • PAR Strong Buy
  • Analyst Count
  • BCYC 9
  • PAR 7
  • Target Price
  • BCYC $44.56
  • PAR $60.86
  • AVG Volume (30 Days)
  • BCYC 218.4K
  • PAR 285.4K
  • Earning Date
  • BCYC 10-31-2024
  • PAR 08-08-2024
  • Dividend Yield
  • BCYC N/A
  • PAR N/A
  • EPS Growth
  • BCYC N/A
  • PAR N/A
  • EPS
  • BCYC N/A
  • PAR 0.06
  • Revenue
  • BCYC $39,574,000.00
  • PAR $425,933,000.00
  • Revenue This Year
  • BCYC $59.17
  • PAR N/A
  • Revenue Next Year
  • BCYC N/A
  • PAR $17.49
  • P/E Ratio
  • BCYC N/A
  • PAR $1,088.31
  • Revenue Growth
  • BCYC 75.74
  • PAR 29.65
  • 52 Week Low
  • BCYC $12.54
  • PAR $28.21
  • 52 Week High
  • BCYC $27.24
  • PAR $55.77
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 34.76
  • PAR 52.31
  • Support Level
  • BCYC $20.02
  • PAR $51.39
  • Resistance Level
  • BCYC $22.10
  • PAR $55.22
  • Average True Range (ATR)
  • BCYC 0.99
  • PAR 1.58
  • MACD
  • BCYC -0.24
  • PAR -0.29
  • Stochastic Oscillator
  • BCYC 14.86
  • PAR 31.05

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

About PAR PAR Technology Corporation

PAR Technology Corp together with its subsidiaries provides management technology solutions including software, hardware, and related services, integral to the point-of-sale infrastructure and task management, information gathering, assimilation, and communication services. It has two segments. The restaurant/ Retail segment provides point-of-sale and management technology solutions such as hardware, software, and integrated technical solutions to the restaurant and retail industries. The government segment provides intelligence, surveillance, and reconnaissance solutions and mission systems support. The company derives the majority of its revenues from the Restaurant/ Retail segment.

Share on Social Networks: